Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, 'Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012" provides data on the Epidermolysis Bullosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Epidermolysis Bullosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Epidermolysis Bullosa. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012
Published on October 2012
Report Summary
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, 'Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012" provides data on the Epidermolysis
Bullosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Epidermolysis
Bullosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also
provides briefing pertaining to the number of trials for the key drugs for treating Epidermolysis Bullosa. This report is built using data
and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of
industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated
disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and
Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Epidermolysis Bullosa 6
Report Guidance 6
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012 (From Slideshare) Page 1/6

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Unaccomplished Trials of Epidermolysis Bullosa 19
Subjects Recruited Over a Period of Time 21
Prominent Sponsors 22
Top Companies Participating in Epidermolysis Bullosa Therapeutics Clinical Trials 24
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Scioderm 26
Clinical Trial Overview of Scioderm 26
Birken AG 27
Clinical Trial Overview of Birken AG 27
Cellerix, S.A. 28
Clinical Trial Overview of Cellerix, S.A. 28
Healthpoint Biotherapeutics 29
Clinical Trial Overview of Healthpoint Biotherapeutics 29
RegeneRx Biopharmaceuticals, Inc. 30
Clinical Trial Overview of RegeneRx Biopharmaceuticals, Inc. 30
Intercytex Group plc 31
Clinical Trial Overview of Intercytex Group plc 31
Clinical Trial Overview of Top Universities / Institutes / Hospitals 32
Stanford University 32
Clinical Trial Overview of Stanford University 32
Centre Hospitalier Universitaire de Nice 33
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice 33
Vanderbilt University 34
Clinical Trial Overview of Vanderbilt University 34
University of Minnesota 35
Clinical Trial Overview of University of Minnesota 35
The University of New South Wales 36
Clinical Trial Overview of The University of New South Wales 36
Kawasaki Medical University 37
Clinical Trial Overview of Kawasaki Medical University 37
Institute of Child Health and Hospital for Children 38
Clinical Trial Overview of Institute of Child Health and Hospital for Children 38
Masonic Cancer Center 39
Clinical Trial Overview of Masonic Cancer Center 39
Uppsala University Hospital 40
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012 (From Slideshare) Page 2/6

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Clinical Trial Overview of Uppsala University Hospital 40
King's College London 41
Clinical Trial Overview of King's College London 41
Osaka University 42
Clinical Trial Overview of Osaka University 42
University College London 43
Clinical Trial Overview of University College London 43
Rambam Health Care Campus 44
Clinical Trial Overview of Rambam Health Care Campus 44
Columbia University 45
Clinical Trial Overview of Columbia University 45
Northwestern University 46
Clinical Trial Overview of Northwestern University 46
The Hospital for Sick Children 47
Clinical Trial Overview of The Hospital for Sick Children 47
Five Key Clinical Profiles 48
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68
List of Tables
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Epidermolysis Bullosa Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Epidermolysis Bullosa Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
Epidermolysis Bullosa Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Epidermolysis Bullosa Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Epidermolysis Bullosa Therapeutics Clinical Trials, G7 Countries, 2012* 14
Epidermolysis Bullosa Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Phase, 2012* 16
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 17
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18
Epidermolysis Bullosa Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 19
Epidermolysis Bullosa Therapeutics Market, Global, Terminated Clinical Trials, 2012* 20
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 21
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 23
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 24
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Scioderm, 2012* 26
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Birken AG, 2012* 27
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012 (From Slideshare) Page 3/6

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Cellerix, S.A., 2012* 28
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthpoint Biotherapeutics, 2012* 29
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by RegeneRx Biopharmaceuticals, Inc., 2012* 30
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercytex Group plc, 2012* 31
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 32
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2012* 33
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2012* 34
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2012* 35
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2012* 36
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Kawasaki Medical University, 2012* 37
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Child Health and Hospital for Children,
2012* 38
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012* 39
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Uppsala University Hospital, 2012* 40
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by King's College London, 2012* 41
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2012* 42
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by University College London, 2012* 43
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2012* 44
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012* 45
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 46
Epidermolysis Bullosa Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2012* 47
List of Figures
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Epidermolysis Bullosa Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10
Epidermolysis Bullosa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
Epidermolysis Bullosa Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Epidermolysis Bullosa Therapeutics Clinical Trials, G7 Countries (%), 2012* 14
Epidermolysis Bullosa Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 15
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 16
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 17
Epidermolysis Bullosa Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 18
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 21
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 22
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 24
Epidermolysis Bullosa Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25
GlobalData Methodology 66
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012 (From Slideshare) Page 4/6

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 2 500.00 Quantity: _____
Site License--USD 5 000.00 Quantity: _____
Corporate License--USD 7 500.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012 (From Slideshare) Page 5/6

6. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Epidermolysis Bullosa Global Clinical Trials Review, H2, 2012 (From Slideshare) Page 6/6